npj Vaccines

Article	Citations
Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine	264
Analyzing atomic force microscopy images of virus-like particles by expectation-maximization	208
Safety and immunogenicity of the Sm-p80 GLA-SE schistosomiasis vaccine	153
Vaccination against Onchocerca volvulus induces IgG-mediated protective immunity dependent on neutrophils and complement	136
Tetravalent microprojection-based dengue chimeric virus vaccine raises potent neutralising antibodies in mice	126
The dengue-specific immune response and antibody identification with machine learning	109
Assessing immunogenicity barriers of the HIV-1 envelope trimer	105
A potent and durable malaria transmission-blocking vaccine designed from a single-component 60-copy Pfs230D1 nanoparticle	104
Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys	101
Impact of genotypic variability of measles virus T-cell epitopes on vaccine-induced T-cell immunity	85
Rational development of a combined mRNA vaccine against COVID-19 and influenza	84
Intranasal vaccine for Lyme disease provides protection against tick transmitted Borrelia burgdorferi beyond one year	81
Immunogenicity and safety of a rabies-based highly pathogenic influenza A virus H5 vaccine in cattle	80
Functionality and translation fidelity characterization of mRNA vaccines using platform based mass spectrometry detection	78
Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern	76
Mapping global public perspectives on mRNA vaccines and therapeutics	73
Immunogenicity of PCV13 during Hospitalization soon after infection resolution: Vaccis study	70
Risk assessment of retinal vascular occlusion after COVID-19 vaccination	70
Reverse development of vaccines against antimicrobial-resistant pathogens	68
Influenza A virus in dairy cattle: infection biology and potential mammary gland-targeted vaccines	66
Zika purified inactivated virus (ZPIV) vaccine reduced vertical transmission in pregnant immunocompetent mice	64
Multi-antigen DNA vaccine targeting non-structural proteins confers robust T Cell-mediated protection against Zika virus	63
A viral codon usage strategy enhances antigen production and protection in SFTSV mRNA vaccination	63
Use of equine H3N8 hemagglutinin as a broadly protective influenza vaccine immunogen	60
Single-dose intranasal adenovirus-based RSV vaccines targeting G and M2	60

Tick-borne encephalitis vaccine breakthrough infections induce aberrant T cell and antibody responses to non-structural proteins	58
Immunogenicity of one and two doses of Gardasil®9 in Tanzanian girls in the DoRIS Trial	58
Next-gen novel nanocage-based multivalent vaccine candidate to tackle the rising menace of Mpox	56
Diversity of immunization strongly impacts SARS-CoV-2 antibody function surrogates	55
mRNA-LNP vaccine encoding CDV hemagglutinin confers effective protection in raccoon dogs	51
Immunogenicity and protective efficacy of a rhesus adenoviral vaccine targeting conserved COVID-19 replication transcription complex	50
SARS-CoV-2 vaccination may mitigate dysregulation of IL-1/IL-18 and gastrointestinal symptoms of the post-COVID-19 condition	49
Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice	49
Vaccination with Mincle agonist UM-1098 and mycobacterial antigens induces protective Th1 and Th17 responses	48
Human in vitro modeling of adjuvant formulations demonstrates enhancement of immune responses to SARS-CoV-2 antigen	48
An open repository of COVID-19 vaccine mandate studies with a worked scoping review of quasi-experimental evidence	47
Immunogenicity and efficacy of homologous and heterologous NDV and MVA SARS-CoV-2 vaccines in mice and hamsters	46
IL-12 mRNA-LNP promotes dermal resident memory CD4+ T cell development	44
Antibody responses against influenza A decline with successive years of annual influenza vaccination	44
GP38 as a vaccine target for Crimean-Congo hemorrhagic fever virus	43
PfRH5 vaccine; from the bench to the vial	43
Immune response induced by standard and fractional doses of 17DD yellow fever vaccine	43
A rationally designed antigen elicits protective antibodies against multiple nosocomial Gram-positive pathogens	42
Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants	41
Novel enzymatic DNA produced from a text file achieves comparable immune responses as plasmid vaccine	41
Genome-wide association study of myocarditis and pericarditis following COVID-19 vaccination	40
LmCen−/− based vaccine is protective against canine visceral leishmaniasis following three natural exposures in Tunisia	40
Author Correction: A Pvs25 mRNA vaccine induces complete and durable transmission-blocking immunity to Plasmodium vivax	39
A register and questionnaire study of long-term general health symptoms following SARS-CoV-2 vaccination in Denmark	38
Multivalent cytomegalovirus glycoprotein B nucleoside modified mRNA vaccines did not demonstrate a greater antibody breadth	36
A field test of empathetic refutational and motivational interviewing to address vaccine hesitancy among patients	36
Leishmania tarentolae as a platform for the production of vaccines against viral pathogens	36
Potent and long-lasting humoral and cellular immunity against varicella zoster virus induced by mRNA-LNP vaccine	35
Conjugation of HIV-1 envelope to hepatitis B surface antigen alters vaccine responses in rhesus macaques	35
Mobilizing domestic support for international vaccine solidarity – recommendations for health crisis communication	35
Effect of monovalent COVID-19 vaccines on viral interference between SARS-CoV-2 and several DNA viruses in patients with long-COVID syndrome	35
Toxin expression during Staphylococcus aureus infection imprints host immunity to inhibit vaccine efficacy	34
Dithranol as novel co-adjuvant for non-invasive dermal vaccination	34
Structural insight into the assembly and D antigenicity of polio type 1 stabilized virus-like particles	34
Sequential immunization with chimeric hemagglutinin ΔNS1 attenuated influenza vaccines induces broad humoral and cellular immunity	34
A safe insect-based chikungunya fever vaccine affords rapid and durable protection in cynomolgus macaques	34
A protective measles virus-derived vaccine inducing long-lasting immune responses against influenza A virus H7N9	33
Bivalent norovirus mRNA vaccine elicits cellular and humoral responses protecting human enteroids from GII.4 infection	32
Vaccination of cattle with the Babesia bovis sexual-stage protein HAP2 abrogates parasite transmission by Rhipicephalus microplus ticks	32
Assessing the impact of mRNA vaccination in chronic inflammatory murine model	32
Evaluation of high-throughput sequencing for replacing the conventional adventitious virus detection assays used for biologics	32
Impact of COVID-19 vaccination coverage on global disability burden of Guillain-Barré syndrome	32
Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity	32
A therapeutic hepatitis B mRNA vaccine with strong immunogenicity and persistent virological suppression	31
Self-assembling SARS-CoV-2 spike-HBsAg nanoparticles elicit potent and durable neutralizing antibody responses via genetic delivery	31
Heterologous immunization modulates B-cell epitope competition between helper peptides and the MPER segment in MPER/liposome vaccines	31
Recombinant lipidated FLIPr effectively enhances mucosal and systemic immune responses for various vaccine types	31
Urgency and necessity of Epstein-Barr virus prophylactic vaccines	31
An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis	31
Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2	30

Single dose VSV-based vaccine protects mice against lethal heterologous Crimean-Congo hemorrhagic fever virus challenge	30
Intranasal COVID-19 vaccine induces respiratory memory T cells and protects K18-hACE mice against SARS-CoV-2 infection	29
Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges	29
An epitope-optimized human H3N2 influenza vaccine induces broadly protective immunity in mice and ferrets	29
Replication in human cells supersedes serum antigenic match for the in vivo efficacy of an A/H1N1pdm09 LAIV virus	29
Neoantigen-augmented iPSC cancer vaccine combined with radiotherapy promotes antitumor immunity in poorly immunogenic cancers	29
Optimal deployment of limited vaccine supplies to control mpox outbreaks	28
Strep A: challenges, opportunities, vaccine-based solutions, and economics	28
Novel oral adjuvant to enhance cytotoxic memory like NK cell responses in HIV vaccine platform	27
Immune checkpoint-engineered virus-like particles induce antigen-specific immune tolerance and protect against food allergy	27
Immunogenic recombinant Mayaro virus-like particles present natively assembled glycoprotein	27
COVID-19 vaccination induces distinct T-cell responses in pediatric solid organ transplant recipients and immunocompetent children	27
WHO International Standards for antibodies to HPV6 HPV11 HPV31 HPV33 HPV45 HPV52 and HPV58	27
Engineering the hydroxyl content on aluminum oxyhydroxide nanorod for elucidating the antigen adsorption behavior	27
Immunogenicity of 2 therapeutic mosaic HIV-1 vaccine strategies in individuals with HIV-1 on antiretroviral therapy	27
The TLR7/8 agonist INI-4001 enhances the immunogenicity of a Powassan virus-like-particle vaccine	27
Realising the potential of correlates of protection for vaccine development, licensure and use: short summary	26
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans	26
Prefusion-stabilized SARS-CoV-2 spike reshapes antigenic hierarchy and antibody targeting against conserved and occluded epitopes	26
Author Correction: Regulatory review of benefits and risks of preventing infant RSV disease through maternal immunization	26
Broad protection and respiratory immunity of dual mRNA vaccination against SARS-CoV-2 variants	26
Long term T cell response and safety of a tetravalent dengue vaccine in healthy children	26
Vector-directed immunity and boosting capacity of VRP-srRNA anti-tumor vaccines	25
BPZE1 vaccination induces IL-17+ and IL-22+ CD4+ T cells associated with nasal mucosal secretory IgA responses in humans: effects on virulent Bordetella pertussis colonisation	25
A safe and potentiated multi-type HPV L2-E7 nanoparticle vaccine with combined prophylactic and therapeutic activity	25
Cancer vaccines and RNA therapeutics: exploring the impact of microRNAs	25
Continuing development of vaccines and monoclonal antibodies against Zika virus	25
mRNA vaccines induce rapid antibody responses in mice	25
Modulation of oral vaccine efficacy by the gut microbiota	24
The Streptococcus pyogenes vaccine landscape	24
Effectiveness of “naturalness” value-based narrative intervention on vaccination acceptance in two randomized controlled trials	24
Enhanced attenuation of chikungunya vaccines expressing antiviral cytokines	24
C5aR+ dendritic cells fine-tune the Peyer’s patch microenvironment to induce antigen-specific CD8+ T cells	24
A broadly protective vaccine against cutaneous human papillomaviruses	24
Analyzing immune responses to varied mRNA and protein vaccine sequences	24
A candidate subunit vaccine induces protective immunity against Mycobacterium avium subspecies paratuberculosis in mice	24
Toxoplasmosis vaccines: what we have and where to go?	24
Esoteric beliefs and CAM impact SARS-CoV-2 immunization drivers, uptake and pediatric immunization views in Germany	24
Cellular immune breadth of an Omicron-specific, self-amplifying monovalent mRNA vaccine booster for COVID-19	23
Transcriptional signature of durable effector T cells elicited by a replication defective HCMV vaccine	23
The need for a clinical case definition in test-negative design studies estimating vaccine effectiveness	23
Retraction Note: Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies	23
Deglycosylation of eukaryotic-expressed flagellin restores adjuvanticity	22
Adenovirus type 5-expressing Gn induces better protective immunity than Gc against SFTSV infection in mice	22
Functional antibody signatures following therapeutic immunization in Simian and Human immunodeficiency virus infection	22
Cocktail vaccine induces immunoprotection and modulates the fecal microbiota in dogs against Echinococcus granulosus infection	22
COVID-19 and influenza vaccine uptake among pregnant women in national cohorts of England and Wales	22
Autogenous vaccines: an alternative approach to disease control in poultry	22
Chimeric hemagglutinin and M2 mRNA vaccine for broad influenza subtype protection	22
A lipidated TLR7/8 adjuvant enhances the efficacy of a vaccine against fentanyl in mice	22
Accelerating the manufacturing of HIV Env protein vaccines for early phase clinical evaluation	22
Elicitation of liver-stage immunity by nanoparticle immunogens displaying P. falciparum CSP-derived antigens	21
Live-attenuated ME49Δcdpk3 strain of Toxoplasma gondii protects against acute and chronic toxoplasmosis	21
Impact of inactivated vaccine on transmission and evolution of H9N2 avian influenza virus in chickens	21
Streptococcus pyogenes vaccine candidates do not induce autoimmune responses in a rheumatic heart disease model	21
Moderate to severe SARS-CoV-2 infection primes vaccine-induced immunity more effectively than asymptomatic or mild infection	21
Multifunctional IgG/IgM antibodies and cellular cytotoxicity are elicited by the full-length MSP1 SumayaVac-1 malaria vaccine	21
Development of in vitro airway epithelial model to assess immune response and safety of mucosal adjuvants	21
An attachment glycoprotein nanoparticle elicits broadly neutralizing antibodies and protects against lethal Nipah virus infection	21
Comparison of rArt v 1-based sublingual and subcutaneous immunotherapy in a murine model of asthma	21
Preexisting IgG forms immune complexes and links local thermal reactogenicity with immunogenicity in influenza vaccination	21
Rapid emergence and transmission of virulence-associated mutations in the oral poliovirus vaccine following vaccination campaigns	21
Adjuvant-induced macrophage activation compromises BA71ΔCD2-mediated protection against African swine fever virus	21
Evaluation of cross-functional antibody responses elicited by a four-component GMMA Shigella vaccine	21
Establishing an immune correlate of protection for Nipah virus in nonhuman primates	21
Transfer of breast milk IgA to infants after oral bivalent norovirus vaccination of post-partum women	20
B cells oppose Mycoplasma pneumoniae vaccine enhanced disease and limit bacterial colonization of the lungs	20
Long-term outcome of patients with vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis	20
Antigen identification strategies and preclinical evaluation models for advancing tuberculosis vaccine development	20
Polyfunctional CD4 T-cells correlating with neutralising antibody is a hallmark of COVISHIELDTM and COVAXIN® induced immunity in COVID-19 exposed Indians	20
From promise to pitfalls: immunological lessons from dengue vaccines and their implications	20
A highly immunogenic vaccine platform against encapsulated pathogens using chimeric probiotic Escherichia coli membrane vesicles	20
Efficacy of the meningococcal vaccine against Neisseria gonorrhoeae: a randomised clinical trial (MenGO)	20
Author Correction: Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population	20
Next-generation mRNA vaccines eliciting robust protection against multidrug-resistant Enterobacteriaceae	20
Intranasal influenza-vectored vaccine expressing pneumococcal surface protein A protects against Influenza and Streptococcus pneumoniae infections	20
mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response	20
Identifying Plasmodium P36 and P52 antigens for coadministration with circumsporozoite protein to enhance vaccine efficacy	19
Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial	19
Safety and efficacy of C. muridarum vaccines adjuvanted with CpG-1826 and four concentrations of Montanide-ISA-720-VG	19

NHBA antibodies elicited by 4CMenB vaccination are key for serum bactericidal activity against Neisseria gonorrhoeae	19
An HLAII-targeted DNA vaccine against influenza H7N9 protected mice and ferrets from a virus challenge	19
Long-term trial of protection provided by adenovirus-vectored vaccine expressing the PPRV H protein	19
A highly immunogenic UVC inactivated Sabin based polio vaccine	19
Development of pre-pandemic influenza candidate vaccine viruses for use in vaccine manufacturing	19
Is new dengue vaccine efficacy data a relief or cause for concern?	19
An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses	19
Vaccination in individuals with Down syndrome: immune vulnerability, safety, efficacy and opportunities	19
Cancer type and gene signatures associated with breakthrough infections following COVID-19 mRNA vaccination	19
Safety and immunogenicity of SARS-CoV-2 vaccine MVC-COV1901 in Taiwanese adolescents: a randomized phase 2 trial	19
A scoping review of global COVID-19 vaccine hesitancy among pregnant persons	19
Genetic ancestry and population structure of vaccinia virus	19
The scientific journey of a novel adjuvant (AS37) from bench to bedside	19
Computationally designed Spike antigens induce neutralising responses against the breadth of SARS-COV-2 variants	19
Modified influenza M158–66 peptide vaccination induces non-relevant T-cells and may enhance pathology after challenge	19
Long-term efficacy of an inactivated H5N1 whole-particle influenza vaccine in nonhuman primates	19
Persistence of hepatitis E vaccine-induced antibody response across different dosage schedules and baseline serostatus	18
Publisher Correction: AI-driven epitope prediction: a systematic review, comparative analysis, and practical guide for vaccine development	18
Progress with COVID vaccine development and implementation	18
A broad spectrum Shigella vaccine based on VirG53–353 multiepitope region produced in a cell-free system	18
Precocious Eimeria magna transgenically expressing RHDV P2 subdomain induces immune responses in rabbits	18
Inverted H1 hemagglutinin nanoparticle vaccines protect mice against challenges with human H1N1 and bovine H5N1 influenza viruses	18
Intranasal immunization with avian paramyxovirus type 3 expressing SARS-CoV-2 spike protein protects hamsters against SARS-CoV-2	18
Self-amplifying COVID-19 mRNA vaccination induces longitudinally enhanced antibody function in a Phase 3 trial	18
A poorly reactogenic lipid nanoparticle-mRNA vaccine unveils an innate immune pathway for adverse reactions	18
Distinct dynamics of mRNA LNPs in mice and nonhuman primates revealed by in vivo imaging	18
Immunogenicity, immune persistence, and safety of japanese encephalitis vaccine schedules among adults in Ningxia, China	18
Author Correction: Establishing a universal IVRP method for quadrivalent HPV vaccines to replace in vivo potency tests	17
Factors influencing long-term persistence of anti-HBs after hepatitis B vaccination	17
The full health, economic, and social benefits of prospective Strep A vaccination	17
mRNA vaccines with RBD mutations have broad-spectrum activity against SARS-CoV-2 variants in mice	17
Human naïve B cells show evidence of anergy and clonal redemption following vaccination	17
Adverse effects, perceptions and attitudes related to BNT162b2, mRNA-1273 or JNJ-78436735 SARS-CoV-2 vaccines: Population-based cohort	17
Publisher Correction: Modeling gonorrhea vaccination to find optimal targeting strategies that balance impact with cost-effectiveness	17
Plasmablast, memory B cell and T follicular helper cell responses after human papillomavirus vaccination: effect of dose number and age	17
To generate functional anti-protease-activated receptor-4 (PAR4), a G protein-coupled receptor, antibodies through PAR4-mRNA-LNP immunization	17
Spillover between influenza and COVID-19 vaccination behaviors across pandemic phases and implications for general vaccine hesitancy	17
Proof of concept for a single-dose Group B Streptococcus vaccine based on capsular polysaccharide conjugated to Qβ virus-like particles	17
Vaccine-induced time- and age-dependent mucosal immunity to gastrointestinal parasite infection	17
Intranasal boosting enhances genital tract T cell immunity following ChAdOx1/MVA hrHPV therapeutic vaccination	17
Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model	17
Modular assembly and immunological evaluation of a promising bioconjugate nanovaccine against Klebsiella pneumoniae O2 serotype	17
OpcA and PorB are novel bactericidal antigens of the 4CMenB vaccine in mice and humans	16
Systems vaccinology identifies immunological correlates of SARS-CoV-2 vaccine response in solid organ transplant recipients	16
Mycobacterium tuberculosis bacteriology and immunity necessitate a multi-pronged immune strategy for vaccination	16
A virus-like particle-based bivalent PCSK9 vaccine lowers LDL-cholesterol levels in non-human primates	16
Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant	16
Author Correction: Selectively targeting haemagglutinin antigen to chicken CD83 receptor induces faster and stronger immunity against avian influenza	16
Increased neonatal vaccine dose or booster immunization prevents hepatitis B vaccine breakthrough infection in children from HBsAg and HBeAg positive mothers	16
Gut microbiota modulate immune responses to orally and parenterally administered rotavirus in mice	16
Filovirus vaccines as a response paradigm for emerging infectious diseases	16
Cyclic di AMP phosphodiesterase nanovaccine elicits protective immunity against Burkholderia cenocepacia infection in mice	16
Author Correction: The dengue-specific immune response and antibody identification with machine learning	16
Retraction Note: Comparing Moderna’s mRNA-1083 and Pfizer’s dual-target mRNA vaccines for influenza and COVID-19	16
Impact of mandatory vaccination against serogroup C meningococci in targeted and non-targeted populations in France	16
A functional enzymatic assay as potential readout for a clinical trial of a schistosomiasis vaccine	16
A centralised immunogen approach to develop a more broadly protective modified live porcine reproductive and respiratory syndrome virus 1 vaccine candidate	16
CD4 T cell epitope abundance in ferritin core potentiates responses to hemagglutinin nanoparticle vaccines	15
Optimization of an alum-anchored clinical HIV vaccine candidate	15
A phase I clinical study to assess safety and immunogenicity of yellow fever vaccine	15
The immunological interplay between vaccination and the intestinal microbiota	15
Identification and efficacy assessment of novel immunoprotective antigens from Mycoplasma synoviae for vaccine development	15
Correlates of immunity to Group A Streptococcus: a pathway to vaccine development	15
Evaluation of the effectiveness of social mobilization for vaccination among healthcare and non-healthcare workers in emergency situations	15
iDC-targeting PfCSP mRNA vaccine confers superior protection against Plasmodium compared to conventional mRNA	15
An intranasal combination vaccine induces systemic and mucosal immunity against COVID-19 and influenza	15
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination	15
A randomised trial of malaria vaccine R21/Matrix-M™ with and without antimalarial drugs in Thai adults	15
Systematic review of evidence on feasibility of administering intranasal live attenuated influenza vaccine at home	15
Reduced dengue virus pre-membrane protein-HMGB1 interaction activates host cell transcription to attenuate infection	15
Pro-inflammatory cytokine profiles and neutralizing antibodies in JYNNEOS-vaccinated and mpox-diagnosed individuals	14
Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine development	14
Autologous dendritic cell vaccination against HIV-1 induces changes in natural killer cell phenotype and functionality	14
A DNA vaccine candidate delivered by an electroacupuncture machine provides protective immunity against SARS-CoV-2 infection	14
ASP-2/Trans-sialidase chimeric protein induces robust protective immunity in experimental models of Chagas’ disease	14
Irradiated whole cell Chlamydia vaccine confers significant protection in a murine genital tract challenge model	14
A Rift Valley fever mRNA vaccine elicits strong immune responses in mice and rhesus macaques	14
Identifying vaccine-hesitant subgroups in the Western Pacific using latent class analysis	14
Applying causal inference and Bayesian statistics to understanding vaccine safety signals using a simulation study	14
A mosaic influenza virus-like particles vaccine provides broad humoral and cellular immune responses against influenza A viruses	14
A chimeric thermostable M2e and H3 stalk-based universal influenza A virus vaccine	14
Reproducible and later vaccine strain selection can improve vaccine match to A/H3N2 seasonal influenza viruses	14
Divergent B-cell repertoire remodelling by mRNA, DNA and live attenuated vaccines in fish	14
Affordable SARS-CoV-2 protein vaccines for the pandemic endgame	14
Proteomic approach to identify host cell attachment proteins provides protective Pseudomonas aeruginosa vaccine antigen FtsZ	14
Reply to: Methodological Issues in Taquet et al.'s analysis preclude any conclusions regarding AS01 adjuvant's specific role in dementia prevention	14
Booster vaccination with Ad26.COV2.S or an Omicron-adapted vaccine in pre-immune hamsters protects against Omicron BA.2	14
Predicted effectiveness of vaccines and extended half-life monoclonal antibodies against RSV hospitalizations in children	14
Loop structure in poly(A) tail of mRNA vaccine enhances antigen translation efficiency and mRNA stability	14
Publisher Correction: Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice	14
A scoping review on the importance of vaccination strategies targeting skin imprinting for arthropod-borne diseases	13
Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants	13
Sterile protection against relapsing malaria with a single-shot vaccine	13
Hepatitis C virus E1 and modified E2 delivered from an mRNA vaccine induces protective immunity	13
ALFQ adjuvanted HIV-1 envelope protein vaccination elicits durable functional antibody and cellular responses in nonhuman primates	13